MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-22-0072183
SN Genelab Private Limited - healthcare in Surat, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹53.84 Cr
▲ 23% YoY
Net profit · FY 2025
₹6.58 Cr
Net margin 12.2%
EBITDA · FY 2025
₹10.88 Cr
EBITDA margin 20.2%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.1 Lakh
Issued & subscribed
Open charges
₹4.27 Cr
Satisfied ₹5 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
36
Provident fund records
About SN Genelab Private Limited
Data last updated:
SN Genelab Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 16 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2013PTC077903. Its GSTIN is 24AAUCS0296F1Z2 (Gujarat).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.1 Lakh. It is led by directors including Shalin Vaniawala and Jalpaben Salilbhai Vaniawala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2nd Floor 'A' Tower President Plaza Near Rto Circle Nanpura Ring Road, Surat, Gujarat, India – 395001.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.84 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹6.58 Cr (net margin 12.2%) and EBITDA of ₹10.88 Cr (EBITDA margin 20.2%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 34% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.27 Cr and satisfied charges of ₹5 Cr on record. The company has 3 deals on record (1 secondary share transfer, 1 acquisition, 1 rights issue); the latest was in September 2026. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 1 smaller; the largest is S Serum Analysis Centre Private Limited with revenue of ₹57.77 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 10 overdue payments to 2 micro and small suppliers.
SN Genelab Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0072183). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sngenelab.com.
Company details
CIN U24230GJ2013PTC077903
Registration Number 077903
Incorporation Date 16 December 2013
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-22-0072183
Key People
Shalin Vaniawala Director Jalpaben Salilbhai Vaniawala Director Salil Nirmalbhai Vaniawala Director Recognitions & Rankings of SN Genelab
Contact details
SN Genelab Private Limited's registered office is in Surat, Gujarat. Its website is sngenelab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2nd Floor 'A' Tower President Plaza Near Rto Circle Nanpura Ring Road, Surat, Gujarat, India – 395001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of SN Genelab Private Limited, buy the company report.
Comprehensive company report
SN Genelab Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of SN Genelab is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of SN Genelab Private Limited, buy the company report.
Financials of SN Genelab Private Limited
FY 2025 filings availableSN Genelab Private Limited reported revenue of ₹53.84 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹53.84 Cr ▲ 23%
Net profit · FY 2025
₹6.58 Cr margin 12.2%
EBITDA · FY 2025
₹10.88 Cr margin 20.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 24%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 16%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 23% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.88 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.2% | ||||
| Net Profit Margin | 12.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SN Genelab Private Limited, buy the company report.
Board of directors of SN Genelab Private Limited
SN Genelab has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shalin Vaniawala | Director | 02 Apr 2022 | 4 Years 6 Months | Current |
| Jalpaben Salilbhai Vaniawala | Director | 16 Dec 2013 | 12 Years 10 Months | Current |
| Salil Nirmalbhai Vaniawala | Director | 16 Dec 2013 | 12 Years 10 Months | Current |
Peer comparison
SN Genelab Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| S Serum Analysis Centre Private Limited | ₹57.77 Cr (FY 2024) | 6.0% | Kolkata, West Bengal, India | |||
| Medcis Pathlabs India Private Limited | ₹57.23 Cr (FY 2024) | 8.0% | Secunderabad, Telangana, India | |||
| SN Genelab Private Limitedthis company | ₹53.84 Cr (FY 2025) | ₹6.58 Cr | 12.2% | 23.0% | 36 | Surat, Gujarat, India |
| Dr. B. Lal Clinical Laboratory Private Limited | ₹52.26 Cr (FY 2025) | 13.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of SN Genelab Private Limited, buy the company report.
Auditor
SN Genelab Private Limited is audited by Pradeep K. Singhi & Associates. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Pradeep K. Singhi & Associates. | FY 2023 | 126027W |
Shareholding
The shareholding of SN Genelab Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SN Genelab Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.27 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2025 | 101100241 | Hdfc Bank Limited | ₹4.27 Cr | Open | |
| 10 Feb 2022 | 100539837 | Hdfc Bank Limited | ₹5 Cr | Satisfied |
To see the full charge records of SN Genelab Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
SN Genelab Private Limited has 3 deals on record (1 secondary share transfer, 1 acquisition, 1 rights issue); the latest was in September 2026.
Total deals
3
Secondary share transfer
1
Acquisition
1
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2026 | Acquisition | ₹168 Cr | Buyer: Dr. Lal Pathlabs Limited |
| Apr 2019 | Rights issue | ₹1.8 Cr | Investors: 2 individuals |
| Apr 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving SN Genelab Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
SN Genelab Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 10 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| DSS Takara Bio India Private Limited |
To see the full MSME payment records of SN Genelab Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
SN Genelab Private Limited has a workforce of 36 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
36
Active EPFO establishments
1
Employee growth
20%
GST
SN Genelab has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAUCS0296F1Z2 | Gujarat | Active | 06 Nov 2023 |
To see the full GST registrations and return filing status of SN Genelab Private Limited, buy the company report.
Recent activity
SN Genelab Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Pratap Narayan Mukhopadhyaya ceased to be Director on 31 Dec 2024.
AGM
Sn Genelab Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 427.16 Lakh with Charge ID 101100241 was registered on 15 May 2025.
Charges
A charge registered on 10 Feb 2022 via Charge ID 100539837 with Hdfc Bank Limited was fully satisfied on 03 May 2025.
Filing
Sn Genelab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Pratap Narayan Mukhopadhyaya ceased to be Director.
Appointed
Shalin Vaniawala was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 500.00 Lakh with Charge ID 100539837 was registered on 10 Feb 2022.
Appointed
Jalpaben Salilbhai Vaniawala was appointed as Director.
Appointed
Salil Nirmalbhai Vaniawala was appointed as Director.
Incorporation
16 Dec 2013
Sn Genelab Private Limited was registered on 16 Dec 2013 with Roc Ahmedabad & aged 12 years 10 months as per MCA records.
News
Frequently asked questions
SN Genelab is an active private limited company based in Surat, Gujarat, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 16 December 2013 (13+ years old) and is registered under CIN U24230GJ2013PTC077903.
SN Genelab has 3 current directors:
- Shalin Vaniawala - Director
- Jalpaben Salilbhai Vaniawala - Director
- Salil Nirmalbhai Vaniawala - Director
The latest financial statements of SN Genelab on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of SN Genelab is 24AAUCS0296F1Z2, registered in Gujarat.
The CIN (Corporate Identification Number) of SN Genelab is U24230GJ2013PTC077903. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SN Genelab was incorporated on 16 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
SN Genelab has 3 deals on record (1 secondary share transfer, 1 acquisition, 1 rights issue); the latest was in September 2026.
The peers of SN Genelab by revenue are S Serum Analysis Centre Private Limited, Medcis Pathlabs India Private Limited, Dr. B. Lal Clinical Laboratory Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Pratap Narayan Mukhopadhyaya ceased to be Director on 31 Dec 2024. Shalin Vaniawala was appointed as Director on 02 Apr 2022. Jalpaben Salilbhai Vaniawala was appointed as Director on 16 Dec 2013. SN Genelab has 4 board changes on record in total.
Yes, SN Genelab is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-22-0072183).
SN Genelab has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 10 overdue payments to 2 micro and small suppliers. The latest return was filed on 08 Jun 2019.
SN Genelab can be reached through the website sngenelab.com. Its registered office is in Surat, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages